HDAC9 and acute promyelocytic leukemia: Although HDAC inhibitors are strongly cytotoxic against APL cells[7]–[9] and other cancerous cells [10]–[12], they exhibit a limited potential for inducing cellular differentiation in APL cells [7], [9], [13], [14].